Claims

Health care professionals show substantial knowledge gaps about clozapine side effects, especially myocarditis and seizures

Claim · All claims
Evidence · 1 study · review r3 · q2
Currency · newest study 2025 · not yet checked against its sources · not reviewed by a person · recheck by 2030: baselines and conditions change

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? Surveys of psychiatric nurses and psychiatrists found large proportions answered incorrectly about serious side-effect risks, e.g. 95.3% (n = 123) of nurses answered incorrectly on myocarditis risk and 70.5% (n = 91) on seizure risk. → Secchi Agostina 2025

Evidence

Secchi Agostina 2025

Secchi Agostina, Whiskey Eromona, Nair Sajitha, Shergill Sukhi, Thomas Trudy. (2025). Competence and confidence of health care professionals in using clozapine: a qualitative systematic review and thematic synthesis. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2025.10024

q2 · i? · review · r3

Survey evidence reported within the review: registered psychiatric mental health nurses questioned about clozapine side-effect risks largely answered incorrectly, with "95.3% (n = 123) answered incorrectly on myocarditis risk". Similar gaps were reported for psychiatrists.

"70.5% (n = 91) of the nurses surveyed by Sanjeevi and Cocoman gave incorrect answers when questioned about the risk of seizures; 65.1% (n = 84) gave incorrect answers when questioned about the risk of metabolic effects and 95.3% (n = 123) answered incorrectly on myocarditis risk."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-31
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.